Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Post-Anesthesia Discharge in Breast Cancer Surgery
NCT07180810Completed
- Sponsor
- Shaukat Khanum Memorial Cancer Hospital & Research Centre
- Start
- Sep 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in breast cancer comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Frequency of early discharge at 120 minutes. Started Sep 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07180810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07180810.